Premium
Auditory Function after Continuous Infusion of Gentamicin to High‐risk Newborns
Author(s) -
COLDING H.,
ANDERSEN E. A.,
PRYTZ S.,
WULFFSBERG H.,
ANDERSEN G. E.
Publication year - 1989
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1989.tb11160.x
Subject(s) - medicine , gentamicin , intensive care , audiometry , anesthesia , ototoxicity , continuous infusion , hearing loss , pediatrics , audiology , surgery , intensive care medicine , antibiotics , chemotherapy , cisplatin , microbiology and biotechnology , biology
. Audiometry was performed at four years of age in 69 of 105 surviving children who had received continuous intravenous infusion of gentamicin during neonatal intensive care. A hearing loss of 20 dB was found in 2 of them (3 %), corresponding to that shown in other studies of survivors following neonatal intensive care. Free field audiometry performed in another 7 children and questionnaires returned from 13 of the remaining 29 gave no suspicion of hearing loss. Thus there is no indication that continuous 24 hours intravenous infusion of gentamicin causes more hearing impairment than intermittent intravenous or intramuscular administration.